spacer
home > pmps > winter 2002 > temperature data logging - a primer
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Temperature Data Logging - A Primer

Why Do We Need Temperature Data Loggers?

Data loggers are now widely used in many trades; not least in the food and pharmaceutical industries where issues of 'quality' and human safety are involved. The chill chain describes the handling processes an item requires as it passes from the point of production to the end user. Time and distance will separate the beginning from the end of the chain. The links in the chain are the various handling points through which the consignment passes.

When dealing with perishable products within the chill chain, temperature control is vital in determining a safe and satisfactory outcome. Manufacturers and distribution companies strive to ensure that all products arrive at the destination in the best condition possible, but sometimes things go wrong.

The control of temperature is probably the most fundamental factor in reducing the amount of spoilage of perishable goods. Testing for spoilage can be both expensive and time-consuming, and for chilled food products the delay whilst bacterial testing is carried out is likely to lead to further deterioration in quality. This may considerably shorten the time during which the product can be offered for sale. For medical products, the necessary testing facilities may not be available.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Tom Lewis, Managing Director of VISiTEMP Limited
Tom Lewis BSc, is Managing Director of VISiTEMP Limited. He has been involved in the design of data loggers since 1984, publishing several papers on temperature data logging, and has travelled extensively advising on the shipment of perishable cargoes.

His background prior to this was in the agricultural industry where he worked in tropical agriculture and as an animal nutritionist and agricultural adviser in the UK.

spacer
Tom Lewis
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Significant improvement in overall survival with ERLEADA®▼ (apalutamide) for patients with non-metastatic castration-resistant prostate cancer

BEERSE, BELGIUM, May 14, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the final analysis of the pivotal Phase 3 SPARTAN study demonstrating ERLEADA®▼ (apalutamide) in combination with androgen deprivation therapy (ADT) significantly improved overall survival (OS), compared to ADT alone, in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) who were at high risk of developing metastases.1 Results will be presented at the American Society of Clinical Oncology (ASCO) Virtual Scientific Programme (Abstract #5516) beginning on Friday 29th May.
More info >>

White Papers

Six Strategies to Stretch Your Limited Drug Supply for Clinical Studies

PCI Pharma Services

Bringing a new drug to market can be a heavy financial burden on any pharmaceutical company. It has become even more burdensome over the last several years as the industry pushes the boundaries of innovation. This is because newer, often more-complex therapies not only increase risk in drug development but also drive costs even higher. A recent analysis of the investment needed to develop a new prescription medicine shows the total cost can be as high as $2.6 billion (1). That number becomes even more staggering when you consider the fact that only about 12 percent of drug candidates that make it to Phase I testing are eventually approved by the FDA (2). The investment companies lose as a result may be too devastating to their bottom line to ever recover.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement